Should I Invest In British American Tobacco Plc Now?

Can British American Tobacco plc (LON: BATS) still deliver a decent investment return?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Cigarette manufacturer British American Tobacco (LSE: BATS) (NYSE: BTI.NY) enjoys a 42% equity position in its tobacco peer Reynolds American. That connection comes under the spotlight this week as Reynold American confirms its acquisition of another industry player Lorilland, which could involve some of both companies’ assets going to yet another tobacco firm, London-listed Imperial Tobacco.

Pulling together

British American Tobacco makes its position clear: the firm intends to support the transaction by subscribing for additional shares in Reynolds American, with the aim of maintaining its 42% equity position.

Such consolidation and close working seems vital in what appears to be an industry in structural decline. If one firm is a better fit for a particular market, why should tobacco sellers fight it out? Far better to co-operate and combine for mutual benefit, just as this potential deal suggests is happening in the industry.

Declining sales volumes

Last year British American Tobacco’s sales volumes declined around 2.7% even though the firm reckons it’s winning market share. That’s strong evidence of a slipping industry; yet, overall, BATS trading delivers a flat-looking performance on revenue and cash flow:

Year to December

2009

2010

2011

2012

2013

Revenue (£m)

14,208

14,883

15,399

15,190

15,260

Net cash from operations (£m)

3,878

4,490

4,566

4,427

4,436

Adjusted earnings per share

153.8p

176.7p

195.8p

208.6p

217.4p

Dividend per share

99.5p

114.2p

126.5p

134.9p

142.4p

A steady stream of repeat business from addicted smokers delivers cash flow, which the firm uses to buy back its own shares to drive up earnings-per-share and dividend-per-share figures.

So far, BATS’ market-share gains are keeping cash flow steady. However, it won’t take much for industry volume declines to tip the balance over market-share gains, which could lead to cash flow decline. That could threaten dividend progression.

So potential industry supporting deals like this one should help tobacco producers such as BATS to keep the cash taps open by extracting every last puff of revenue from smokers as efficiently as possible.

Valuation

At a share price of 3586p, BATS shares change hands on a forward P/E multiple of just under 16 for 2015. City analysts reckon the firm should see 8% growth in its earnings that year and the dividend will likely yield upwards of 4.4%. Forward earnings will cover the payout about one-and-a-half times based on current predictions.

There’s no doubt that British American Tobacco is operating as something of a cash-cow, managing to drive the dividend payment up year after year. However, I can’t bring myself to invest in a firm with poor revenue prospects no matter how well it manages its cash supply for investor income.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Kevin does not own shares in British American Tobacco.

More on Investing Articles

Fireworks display in the shape of willow at Newcastle, Co. Down , Northern Ireland at Halloween.
Investing Articles

The Anglo American share price soars to £25, but I’m not selling!

On Thursday, the Anglo American share price soared after mega-miner BHP Group made an unsolicited bid for it. But I…

Read more »

Investing Articles

Now 70p, is £1 the next stop for the Vodafone share price?

The Vodafone share price is back to 70p, but it's a long way short of the 97p it hit in…

Read more »

Concept of two young professional men looking at a screen in a technological data centre
Investing Articles

If I’d put £5,000 in Nvidia stock at the start of 2024, here’s what I’d have now

Nvidia stock was a massive winner in 2023 as the AI chipmaker’s profits surged across the year. How has it…

Read more »

Light bulb with growing tree.
Investing Articles

3 top investment trusts that ‘green’ up my Stocks and Shares ISA

I’ll be buying more of these investment trusts for my Stocks and Shares ISA given the sustainable and stable returns…

Read more »

Investing Articles

8.6% or 7.2%? Does the Legal & General or Aviva dividend look better?

The Aviva dividend tempts our writer. But so does the payout from Legal & General. Here he explains why he'd…

Read more »

a couple embrace in front of their new home
Investing Articles

Are Persimmon shares a bargain hiding in plain sight?

Persimmon shares have struggled in 2024, so far. But today's trading update suggests sentiment in the housing market's already improving.

Read more »

Market Movers

Here’s why the Unilever share price is soaring after Q1 earnings

Stephen Wright isn’t surprised to see the Unilever share price rising as the company’s Q1 results show it’s executing on…

Read more »

Investing Articles

Barclays’ share price jumps 5% on Q1 news. Will it soon be too late to buy?

The Barclays share price has been having a great time this year, as a solid Q1 gives it another boost.…

Read more »